IFITM2 and COVID-19: In HeLa-ACE2 cells, a 4-hour treatment of 20 μM tacrolimus did not reduce IFITM2/-3 levels (Supplemental Figure 5A), nor did it boost HIV-CoV-2 infection (Supplemental Figure 5B).